Biovie Historical Balance Sheet

BIVI Stock

USD 2.82 0.18 6.00%

Trend analysis of Biovie Inc balance sheet accounts such as Total Current Liabilities of 5.1 M, Total Stockholder Equity of 16.3 M or Accounts Payable of 3.8 M provides information on Biovie's total assets, liabilities, and equity, which is the actual value of Biovie Inc to its prevalent stockholders. By breaking down trends over time using Biovie balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Biovie Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biovie Inc is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About Biovie Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biovie Inc at a specified time, usually calculated after every quarter, six months, or one year. Biovie Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biovie and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biovie currently owns. An asset can also be divided into two categories, current and non-current.

Biovie Balance Sheet Chart

As of now, Biovie's Cash is increasing as compared to previous years. The Biovie's current Cash And Short Term Investments is estimated to increase to about 25 M, while Total Current Liabilities is projected to decrease to under 5.1 M.

Total Assets Total Current Liabilities Net Debt Accounts Payable Cash And Short Term Investments Liabilities And Stockholders Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Biovie assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biovie Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biovie balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biovie Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Accounts Payable

An accounting item on the balance sheet that represents Biovie obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Biovie Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Biovie Inc balance sheet. This account contains Biovie investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Biovie Inc fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.

Most accounts from Biovie's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biovie Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	4.2M	14.5M	9.4M	5.1M
Total Assets	20.1M	35.1M	25.2M	26.5M

Total Current Liabilities Total Assets

Biovie balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Net Tangible Assets	Common Stock Shares Outstanding	Non Current Assets Total	Non Currrent Assets Other	Good Will	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Net Invested Capital	Net Working Capital
Total Assets		0.45	0.73	-0.79	-0.92	0.51	0.95	1.0	-0.33	0.52	0.93	0.61	1.0	-0.23	0.04	0.73	0.68	0.12	-0.07	0.52	0.33	-0.12	0.78	-0.48	0.89	0.84
Total Current Liabilities	0.45		-0.23	-0.22	-0.4	0.32	0.36	0.43	-0.35	0.17	0.36	0.92	0.44	-0.33	0.88	-0.22	0.79	0.19	-0.06	0.44	0.6	0.09	0.32	-0.47	0.05	-0.08
Total Stockholder Equity	0.73	-0.23		-0.72	-0.69	0.41	0.73	0.74	-0.07	0.2	0.72	-0.1	0.73	0.03	-0.64	0.99	0.17	-0.03	-0.05	0.22	-0.15	-0.21	0.52	-0.13	0.94	0.96
Net Debt	-0.79	-0.22	-0.72		0.87	-0.85	-0.91	-0.79	0.31	-0.17	-0.89	-0.28	-0.79	0.18	0.16	-0.76	-0.68	-0.02	0.09	-0.41	-0.31	0.24	-0.5	0.32	-0.87	-0.82
Retained Earnings	-0.92	-0.4	-0.69	0.87		-0.62	-0.95	-0.92	0.4	-0.45	-1.0	-0.54	-0.92	0.31	-0.04	-0.7	-0.69	-0.11	0.08	-0.55	-0.44	0.14	-0.85	0.53	-0.85	-0.81
Accounts Payable	0.51	0.32	0.41	-0.85	-0.62		0.65	0.49	-0.23	-0.21	0.64	0.21	0.49	-0.1	0.02	0.45	0.72	0.23	0.04	0.49	0.36	-0.01	0.17	-0.4	0.58	0.48
Cash	0.95	0.36	0.73	-0.91	-0.95	0.65		0.96	-0.36	0.49	0.96	0.53	0.96	-0.25	-0.03	0.75	0.7	0.05	-0.08	0.46	0.36	-0.21	0.71	-0.42	0.92	0.88
Cash And Short Term Investments	1.0	0.43	0.74	-0.79	-0.92	0.49	0.96		-0.35	0.51	0.93	0.6	1.0	-0.25	0.02	0.74	0.66	0.03	-0.08	0.45	0.29	-0.2	0.77	-0.42	0.9	0.85
Common Stock Total Equity	-0.33	-0.35	-0.07	0.31	0.4	-0.23	-0.36	-0.35		-0.18	-0.39	-0.39	-0.34	0.99	-0.27	-0.1	-0.15	0.16	0.02	0.0	0.2	0.24	-0.34	-0.05	-0.21	-0.17
Non Current Liabilities Total	0.52	0.17	0.2	-0.17	-0.45	-0.21	0.49	0.51	-0.18		0.43	0.55	0.51	-0.19	0.13	0.17	0.18	0.1	0.01	0.29	0.32	0.03	0.66	-0.35	0.32	0.4
Other Stockholder Equity	0.93	0.36	0.72	-0.89	-1.0	0.64	0.96	0.93	-0.39	0.43		0.5	0.93	-0.29	-0.01	0.73	0.67	0.1	-0.08	0.53	0.4	-0.15	0.83	-0.51	0.87	0.84
Total Liab	0.61	0.92	-0.1	-0.28	-0.54	0.21	0.53	0.6	-0.39	0.55	0.5		0.6	-0.37	0.79	-0.09	0.76	0.2	-0.04	0.49	0.63	0.07	0.55	-0.54	0.2	0.12
Total Current Assets	1.0	0.44	0.73	-0.79	-0.92	0.49	0.96	1.0	-0.34	0.51	0.93	0.6		-0.25	0.03	0.74	0.66	0.04	-0.08	0.45	0.3	-0.2	0.77	-0.43	0.89	0.85
Common Stock	-0.23	-0.33	0.03	0.18	0.31	-0.1	-0.25	-0.25	0.99	-0.19	-0.29	-0.37	-0.25		-0.29	0.0	-0.06	0.17	0.01	0.05	0.24	0.22	-0.31	-0.09	-0.1	-0.07
Other Current Liab	0.04	0.88	-0.64	0.16	-0.04	0.02	-0.03	0.02	-0.27	0.13	-0.01	0.79	0.03	-0.29		-0.63	0.54	0.18	-0.05	0.26	0.58	0.17	0.1	-0.34	-0.39	-0.49
Net Tangible Assets	0.73	-0.22	0.99	-0.76	-0.7	0.45	0.75	0.74	-0.1	0.17	0.73	-0.09	0.74	0.0	-0.63		0.19	-0.11	-0.06	0.16	-0.15	-0.3	0.5	-0.08	0.95	0.96
Common Stock Shares Outstanding	0.68	0.79	0.17	-0.68	-0.69	0.72	0.7	0.66	-0.15	0.18	0.67	0.76	0.66	-0.06	0.54	0.19		0.22	-0.09	0.58	0.76	0.0	0.4	-0.58	0.45	0.33
Non Current Assets Total	0.12	0.19	-0.03	-0.02	-0.11	0.23	0.05	0.03	0.16	0.1	0.1	0.2	0.04	0.17	0.18	-0.11	0.22		0.09	0.87	0.34	0.96	0.12	-0.65	-0.02	-0.03
Non Currrent Assets Other	-0.07	-0.06	-0.05	0.09	0.08	0.04	-0.08	-0.08	0.02	0.01	-0.08	-0.04	-0.08	0.01	-0.05	-0.06	-0.09	0.09		0.08	-0.11	0.1	-0.06	-0.46	-0.05	-0.05
Good Will	0.52	0.44	0.22	-0.41	-0.55	0.49	0.46	0.45	0.0	0.29	0.53	0.49	0.45	0.05	0.26	0.16	0.58	0.87	0.08		0.59	0.73	0.49	-0.86	0.33	0.29
Other Current Assets	0.33	0.6	-0.15	-0.31	-0.44	0.36	0.36	0.29	0.2	0.32	0.4	0.63	0.3	0.24	0.58	-0.15	0.76	0.34	-0.11	0.59		0.21	0.4	-0.66	0.07	0.02
Intangible Assets	-0.12	0.09	-0.21	0.24	0.14	-0.01	-0.21	-0.2	0.24	0.03	-0.15	0.07	-0.2	0.22	0.17	-0.3	0.0	0.96	0.1	0.73	0.21		-0.03	-0.52	-0.25	-0.25
Short Long Term Debt Total	0.78	0.32	0.52	-0.5	-0.85	0.17	0.71	0.77	-0.34	0.66	0.83	0.55	0.77	-0.31	0.1	0.5	0.4	0.12	-0.06	0.49	0.4	-0.03		-0.55	0.6	0.63
Property Plant And Equipment Net	-0.48	-0.47	-0.13	0.32	0.53	-0.4	-0.42	-0.42	-0.05	-0.35	-0.51	-0.54	-0.43	-0.09	-0.34	-0.08	-0.58	-0.65	-0.46	-0.86	-0.66	-0.52	-0.55		-0.26	-0.22
Net Invested Capital	0.89	0.05	0.94	-0.87	-0.85	0.58	0.92	0.9	-0.21	0.32	0.87	0.2	0.89	-0.1	-0.39	0.95	0.45	-0.02	-0.05	0.33	0.07	-0.25	0.6	-0.26		0.98
Net Working Capital	0.84	-0.08	0.96	-0.82	-0.81	0.48	0.88	0.85	-0.17	0.4	0.84	0.12	0.85	-0.07	-0.49	0.96	0.33	-0.03	-0.05	0.29	0.02	-0.25	0.63	-0.22	0.98

Click cells to compare fundamentals

Biovie Account Relationship Matchups

Biovie balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.1M	6.0M	20.1M	35.1M	25.2M	26.5M
Total Current Liabilities	23.5M	996.4K	4.2M	14.5M	9.4M	5.1M
Total Stockholder Equity	(21.5M)	5.1M	3.7M	15.3M	15.5M	16.3M
Net Debt	873.8K	(4.5M)	(6.4M)	(5.0M)	(17.7M)	(16.8M)
Retained Earnings	(41.0M)	(224.9M)	(251.0M)	(301.2M)	(334.2M)	(317.5M)
Accounts Payable	1.3M	996.4K	2.4K	3.5K	3.6M	3.8M
Cash	37.2K	4.5M	18.6M	19.5M	23.8M	25.0M
Cash And Short Term Investments	37.2K	4.5M	18.6M	33.9M	23.8M	25.0M
Common Stock Total Equity	50.7K	520.0	2.2K	2.5K	2.2K	2.1K
Liabilities And Stockholders Equity	2.1M	6.0M	20.1M	35.1M	25.2M	26.5M
Non Current Liabilities Total	62.5K	0.0	12.3M	5.3M	349.9K	332.4K
Other Stockholder Equity	19.5M	229.9M	254.6M	316.4M	349.7M	367.2M
Total Liab	23.6M	996.4K	16.4M	19.8M	9.7M	6.9M
Total Current Assets	413.0K	4.6M	18.8M	34.0M	24.0M	25.3M
Common Stock	520.0	2.2K	2.5K	3.6K	6.2K	8.0K
Other Current Liab	21.4M	996.4K	4.1M	5.3M	3.8K	3.6K
Net Tangible Assets	(23.2M)	3.6M	2.5M	14.4M	16.5M	17.3M
Common Stock Shares Outstanding	4.9M	1.2M	2.5M	3.2M	4.5M	4.7M
Non Current Assets Total	1.7M	1.4M	1.3M	1.1M	1.2M	1.3M
Other Current Assets	375.8K	187.0K	275.8K	102.5K	204.4K	163.7K
Intangible Assets	1.3M	1.1M	866.5K	637.1K	407.7K	387.3K
Net Invested Capital	(20.6M)	5.1M	15.8M	29.7M	34.1M	35.8M
Net Working Capital	(23.1M)	3.6M	14.6M	19.5M	22.5M	23.6M
Capital Stock	520.0	2.2K	2.5K	3.6K	3.3K	3.1K

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:

How To Invest In Biovie

Details

Is Biovie Stock a good investment?

Details

What is Biovie's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.08)

Return On Assets

(0.67)

Return On Equity

(2.08)

The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biovie Historical Balance Sheet

About Biovie Balance Sheet Analysis

Biovie Balance Sheet Chart

Total Assets

Total Current Liabilities

Net Debt

Accounts Payable

Cash And Short Term Investments

Liabilities And Stockholders Equity

Biovie balance sheet Correlations

Biovie Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biovie balance sheet Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Total Equity
Net Working Capital	+ 0.98	Net Invested Capital

Other Stockholder Equity	- 1.0	Retained Earnings
Cash	- 0.95	Retained Earnings
Total Current Assets	- 0.92	Retained Earnings
Cash And Short Term Investments	- 0.92	Retained Earnings
Retained Earnings	- 0.92	Total Assets
Cash	- 0.91	Net Debt